Physiotherapy Methods for Fibromyalgia
Condition(s) studied
Investigational drug(s) / intervention(s)
Connective tissue massage: Connective tissue massage (CTM) is a manual technique that involves applying specific dragging or pulling movements to the superficial and subcutaneous connective tissue layers
Transcutaneous auricular vagus nerve stimulation: Transcutaneous auricular vagus nerve stimulation (taVNS) is a non-invasive neuromodulation technique. It targets vagus nerve stimulation through the transcutaneous application of electrical impulses to the auricle
Study summary
The aim of our study was to examine and compare the effects of different physiotherapy methods, namely connective tissue massage, transcutaneous auricular vagus nerve stimulation and both, on pain, health status, sleep quality, fatigue, psychosocial status, autonomic symptoms and quality of life in women with fibromyalgia.
Eligibility
Primary outcome measure(s)
- Pain intensity as measured by the Visual Analog Scale (VAS) — Baseline, 6th week (after treatment)
In the VAS scale, which is a 10 cm scale, '0' represents no pain and '10' represents the worst imaginable pain. The distance from the marked point to the 0 point is measured using a ruler, and the pain intensity is recorded in centimeters. - Health status and disease severity as measured by the Fibromyalgia Impact Questionnaire (FIQ). — Baseline, 6th week (after treatment)
This questionnaire assesses the severity of symptoms, overall impact, and physical function. The total score for the questionnaire ranges from 0 to 100, with higher scores indicating a greater impact of the illness on patients.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Gazi Mustafa Kemal Occupational and Environmental Diseases Hospital | Ankara | Turkey (Türkiye) | Recruiting |
More Ankara Yildirim Beyazıt University trials in Turkey
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07425652 on ClinicalTrials.gov ↗ ← All trials in Turkey